FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386101214> ?p ?o ?g. }

• W4386101214 endingPage "175965" @default.
• W4386101214 startingPage "175965" @default.
• W4386101214 abstract "Atherosclerosis (AS)-associated cardiovascular diseases are predominant causes of morbidity and mortality worldwide. Melatonin, a circadian hormone with anti-inflammatory activity, may be a novel therapeutic intervention for AS. However, the exact mechanism is unclear. This research intended to investigate the mechanism of melatonin in treating AS. Melatonin (20 mg/kg/d) was intraperitoneally administered in a high-fat diet (HFD)-induced AS model using apolipoprotein E-deficient (ApoE-/-) mice for 12 weeks. Immunohistochemical and immunofluorescence analyses, data-independent acquisition (DIA)-based protein profiling, ingenuity pathway analysis (IPA), and western blotting were employed to investigate the therapeutic effects of melatonin in treating HFD-induced AS. An adeno-associated virus (AAV) vector was further used to confirm the antiatherosclerotic mechanism of melatonin. Melatonin treatment markedly attenuated atherosclerotic lesions, induced stable phenotypic sclerotic plaques, inhibited macrophage infiltration, and suppressed the production of proinflammatory cytokines in ApoE-/- mice with HFD-induced AS. Notably, DIA-based quantitative proteomics together with IPA identified S100a9 as a pivotal mediator in the protective effects of melatonin. Moreover, melatonin significantly suppressed HFD-induced S100a9 expression at both the mRNA and protein levels. The overexpression of S100a9 significantly activated the NF-κB signaling pathway and markedly abolished the antagonistic effect of melatonin on HFD-induced vascular inflammation during atherogenesis. Melatonin exerts a significant antiatherogenic effect by inhibiting S100a9/NF-κB signaling pathway-mediated vascular inflammation. Our findings reveal a novel antiatherosclerotic mechanism of melatonin and underlie its potential clinical use in modulating AS with good availability and affordability." @default.
• W4386101214 created "2023-08-24" @default.
• W4386101214 creator A5002458192 @default.
• W4386101214 creator A5008091519 @default.
• W4386101214 creator A5012620387 @default.
• W4386101214 creator A5022256556 @default.
• W4386101214 creator A5026624461 @default.
• W4386101214 creator A5033599023 @default.
• W4386101214 creator A5041937252 @default.
• W4386101214 creator A5046218235 @default.
• W4386101214 creator A5056860005 @default.
• W4386101214 creator A5061849234 @default.
• W4386101214 creator A5063159500 @default.
• W4386101214 creator A5065172118 @default.
• W4386101214 creator A5086274163 @default.
• W4386101214 date "2023-10-01" @default.
• W4386101214 modified "2023-10-18" @default.
• W4386101214 title "Melatonin ameliorates atherosclerosis by suppressing S100a9-mediated vascular inflammation" @default.
• W4386101214 cites W2009738292 @default.
• W4386101214 cites W2022779537 @default.
• W4386101214 cites W2033264902 @default.
• W4386101214 cites W2059357159 @default.
• W4386101214 cites W2112337773 @default.
• W4386101214 cites W2595645464 @default.
• W4386101214 cites W2613572458 @default.
• W4386101214 cites W2622196654 @default.
• W4386101214 cites W2624502876 @default.
• W4386101214 cites W2776140356 @default.
• W4386101214 cites W2794941358 @default.
• W4386101214 cites W2808305854 @default.
• W4386101214 cites W2886853896 @default.
• W4386101214 cites W2897949009 @default.
• W4386101214 cites W2926178629 @default.
• W4386101214 cites W2940988070 @default.
• W4386101214 cites W2963590191 @default.
• W4386101214 cites W2964793076 @default.
• W4386101214 cites W2978059917 @default.
• W4386101214 cites W2994799077 @default.
• W4386101214 cites W2996070127 @default.
• W4386101214 cites W2999901765 @default.
• W4386101214 cites W3032452569 @default.
• W4386101214 cites W3084742155 @default.
• W4386101214 cites W3136424241 @default.
• W4386101214 cites W3166266271 @default.
• W4386101214 cites W3173062350 @default.
• W4386101214 cites W3189355281 @default.
• W4386101214 cites W3195878610 @default.
• W4386101214 cites W3209594566 @default.
• W4386101214 cites W3212855607 @default.
• W4386101214 cites W3214952445 @default.
• W4386101214 cites W4200243157 @default.
• W4386101214 cites W4200382571 @default.
• W4386101214 cites W4205358813 @default.
• W4386101214 cites W4210308762 @default.
• W4386101214 cites W4210846134 @default.
• W4386101214 cites W4213153908 @default.
• W4386101214 cites W4224081637 @default.
• W4386101214 cites W4225829480 @default.
• W4386101214 cites W4293789183 @default.
• W4386101214 cites W4307139390 @default.
• W4386101214 cites W4309212264 @default.
• W4386101214 doi "https://doi.org/10.1016/j.ejphar.2023.175965" @default.
• W4386101214 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37625682" @default.
• W4386101214 hasPublicationYear "2023" @default.
• W4386101214 type Work @default.
• W4386101214 citedByCount "0" @default.
• W4386101214 crossrefType "journal-article" @default.
• W4386101214 hasAuthorship W4386101214A5002458192 @default.
• W4386101214 hasAuthorship W4386101214A5008091519 @default.
• W4386101214 hasAuthorship W4386101214A5012620387 @default.
• W4386101214 hasAuthorship W4386101214A5022256556 @default.
• W4386101214 hasAuthorship W4386101214A5026624461 @default.
• W4386101214 hasAuthorship W4386101214A5033599023 @default.
• W4386101214 hasAuthorship W4386101214A5041937252 @default.
• W4386101214 hasAuthorship W4386101214A5046218235 @default.
• W4386101214 hasAuthorship W4386101214A5056860005 @default.
• W4386101214 hasAuthorship W4386101214A5061849234 @default.
• W4386101214 hasAuthorship W4386101214A5063159500 @default.
• W4386101214 hasAuthorship W4386101214A5065172118 @default.
• W4386101214 hasAuthorship W4386101214A5086274163 @default.
• W4386101214 hasConcept C126322002 @default.
• W4386101214 hasConcept C134018914 @default.
• W4386101214 hasConcept C164027704 @default.
• W4386101214 hasConcept C2776914184 @default.
• W4386101214 hasConcept C2778163477 @default.
• W4386101214 hasConcept C2778182776 @default.
• W4386101214 hasConcept C62746215 @default.
• W4386101214 hasConcept C71924100 @default.
• W4386101214 hasConcept C86803240 @default.
• W4386101214 hasConcept C98274493 @default.
• W4386101214 hasConceptScore W4386101214C126322002 @default.
• W4386101214 hasConceptScore W4386101214C134018914 @default.
• W4386101214 hasConceptScore W4386101214C164027704 @default.
• W4386101214 hasConceptScore W4386101214C2776914184 @default.
• W4386101214 hasConceptScore W4386101214C2778163477 @default.
• W4386101214 hasConceptScore W4386101214C2778182776 @default.
• W4386101214 hasConceptScore W4386101214C62746215 @default.
• W4386101214 hasConceptScore W4386101214C71924100 @default.

• next